|
Volumn 296, Issue 1, 2001, Pages 216-223
|
α2-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ASPARTIC ACID;
BRIMONIDINE;
CLONIDINE;
GLUTAMIC ACID;
RAUWOLSCINE;
ALPHA ADRENERGIC STIMULATION;
AMINO ACID METABOLISM;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
B WAVE;
CELL DEATH;
CELL PROTECTION;
CONTROLLED STUDY;
DRUG ANTAGONISM;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RETINA GANGLION CELL;
RETINA ISCHEMIA;
RETROGRADE NERVE FIBER TRANSPORT;
VITREOUS BODY;
ADRENERGIC ALPHA-AGONISTS;
ADRENERGIC ALPHA-ANTAGONISTS;
ANIMALS;
ASPARTIC ACID;
CHROMATOGRAPHY, LIQUID;
ELECTRORETINOGRAPHY;
EXTRACELLULAR SPACE;
GLUTAMIC ACID;
ISCHEMIA;
MALE;
MASS SPECTROMETRY;
QUINOXALINES;
RATS;
RATS, INBRED BN;
RECEPTORS, ADRENERGIC, ALPHA-2;
RETINA;
RETINAL GANGLION CELLS;
RETINAL VESSELS;
VITREOUS BODY;
YOHIMBINE;
|
EID: 0035198185
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (140)
|
References (30)
|